SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Matic Ivan)
 

Sökning: WFRF:(Matic Ivan) > ADP-ribosyltransfer...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00008462naa a2200937 4500
001oai:DiVA.org:uu-497477
003SwePub
008230301s2022 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4974772 URI
024a https://doi.org/10.1111/febs.161422 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Lüscher, Bernhardu Rhein Westfal TH Aachen, Inst Biochem & Mol Biol, Aachen, Germany.4 aut
2451 0a ADP-ribosyltransferases, an update on function and nomenclature
264 c 2021-09-13
264 1b John Wiley & Sons,c 2022
338 a electronic2 rdacarrier
520 a ADP-ribosylation, a modification of proteins, nucleic acids, and metabolites, confers broad functions, including roles in stress responses elicited, for example, by DNA damage and viral infection and is involved in intra- and extracellular signaling, chromatin and transcriptional regulation, protein biosynthesis, and cell death. ADP-ribosylation is catalyzed by ADP-ribosyltransferases (ARTs), which transfer ADP-ribose from NAD+ onto substrates. The modification, which occurs as mono- or poly-ADP-ribosylation, is reversible due to the action of different ADP-ribosylhydrolases. Importantly, inhibitors of ARTs are approved or are being developed for clinical use. Moreover, ADP-ribosylhydrolases are being assessed as therapeutic targets, foremost as antiviral drugs and for oncological indications. Due to the development of novel reagents and major technological advances that allow the study of ADP-ribosylation in unprecedented detail, an increasing number of cellular processes and pathways are being identified that are regulated by ADP-ribosylation. In addition, characterization of biochemical and structural aspects of the ARTs and their catalytic activities have expanded our understanding of this protein family. This increased knowledge requires that a common nomenclature be used to describe the relevant enzymes. Therefore, in this viewpoint, we propose an updated and broadly supported nomenclature for mammalian ARTs that will facilitate future discussions when addressing the biochemistry and biology of ADP-ribosylation. This is combined with a brief description of the main functions of mammalian ARTs to illustrate the increasing diversity of mono- and poly-ADP-ribose mediated cellular processes.
650 7a NATURVETENSKAPx Biologix Biokemi och molekylärbiologi0 (SwePub)106022 hsv//swe
650 7a NATURAL SCIENCESx Biological Sciencesx Biochemistry and Molecular Biology0 (SwePub)106022 hsv//eng
653 a ADP-ribosylation
653 a MARylation
653 a PARP
653 a PARylation
653 a posttranslational modification
700a Ahel, Ivanu Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England.4 aut
700a Altmeyer, Matthiasu Univ Zurich, Dept Mol Mech Dis, Zurich, Switzerland.4 aut
700a Ashworth, Alanu UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA.4 aut
700a Bai, Peteru Univ Debrecen, Fac Med, Dept Med Chem, Debrecen, Hungary.4 aut
700a Chang, Paulu ARase Therapeut, Cambridge, MA USA.4 aut
700a Cohen, Michaelu Oregon Hlth & Sci Univ, Dept Chem Physiol & Biochem, Portland, OR 97201 USA.4 aut
700a Corda, Danielau CNR, Dept Biomed Sci, Rome, Italy.4 aut
700a Dantzer, Francoiseu CNRS, BSC UMR7242, Illkirch Graffenstaden, France.4 aut
700a Daugherty, Matthew D.u Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.4 aut
700a Dawson, Ted M.u Johns Hopkins Univ, Neuroregenerat & Stem Cell Programs, Inst Cell Engn, Sch Med, Baltimore, MD USA.4 aut
700a Dawson, Valina L.u Johns Hopkins Univ, Neuroregenerat & Stem Cell Programs, Inst Cell Engn, Sch Med, Baltimore, MD USA.4 aut
700a Deindl, Sebastianu Uppsala universitet,Molekylär systembiologi4 aut0 (Swepub:uu)sebde386
700a Fehr, Anthony R.u Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.4 aut
700a Feijs, Karla L. H.u Rhein Westfal TH Aachen, Inst Biochem & Mol Biol, Aachen, Germany.4 aut
700a Filippov, Dmitri V.u Leiden Univ, Leiden Inst Chem, Leiden, Netherlands.4 aut
700a Gagné, Jean-Philippeu Laval Univ, Dept Mol Biol Med Biochem & Pathol, Fac Med, Quebec City, PQ, Canada.4 aut
700a Grimaldi, Giovannau CNR, Naples, Italy.4 aut
700a Guettler, Sebastianu Inst Canc Res ICR, Div Struct Biol, London, England.;Inst Canc Res ICR, Div Canc Biol, London, England.4 aut
700a Hoch, Nicolas C.u Univ Sao Paulo, Dept Biochem, Sao Paulo, Brazil.4 aut
700a Hottiger, Michael O.u Univ Zurich, Dept Mol Mech Dis, Zurich, Switzerland.4 aut
700a Korn, Patriciau Rhein Westfal TH Aachen, Inst Biochem & Mol Biol, Aachen, Germany.4 aut
700a Kraus, W. Leeu Univ Texas Southwestern Med Ctr, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX USA.4 aut
700a Ladurner, Andreasu Ludwig Maximilians Univ Munchen, Dept Physiol Chem, Planegg Martinsried, Germany.4 aut
700a Lehtiö, Lariu Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.;Bioctr Oulu, Oulu, Finland.4 aut
700a Leung, Anthony K. L.u Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD USA.4 aut
700a Lord, Christopher J.u Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, CRUK Gene Funct Lab, London, England.4 aut
700a Mangerich, Aswinu Univ Konstanz, Dept Biol, Constance, Germany.4 aut
700a Matic, Ivanu Max Planck Inst Biol Ageing, Cologne, Germany.;Univ Cologne, Cologne Excellence Cluster Stress Responses Agein, Cologne, Germany.4 aut
700a Matthews, Jasonu Univ Oslo, Inst Basic Med Sci, Oslo, Norway.4 aut
700a Moldovan, George-Lucianu Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA USA.4 aut
700a Moss, Joelu NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA.4 aut
700a Natoli, Gioacchinou European Inst Oncol IEO, Dept Expt Oncol, Milan, Italy.4 aut
700a Nielsen, Michael L.u Univ Copenhagen, Novo Nordisk Fdn, Fac Hlth & Med Sci, Prote Program,Ctr Prot Res, Copenhagen, Denmark.4 aut
700a Niepel, Mariou Ribon Therapeut, Cambridge, MA USA.4 aut
700a Nolte, Friedrichu Univ Klinikum Hamburg Eppendorf, Inst Immunol, Hamburg, Germany.4 aut
700a Pascal, Johnu Univ Montreal, Biochem & Mol Med, Montreal, PQ, Canada.4 aut
700a Paschal, Bryce M.u Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA.4 aut
700a Pawlowski, Krzysztofu Univ Texas Southwestern Med Ctr, Dept Mol Biol, Dallas, TX USA.4 aut
700a Poirier, Guy G.u Laval Univ, Dept Mol Biol Med Biochem & Pathol, Fac Med, Quebec City, PQ, Canada.4 aut
700a Smith, Susanu Univ Zurich, Dept Mol Mech Dis, Zurich, Switzerland.;NYU, Kimmel Ctr Biol & Med, Dept Pathol, Skirball Inst,Sch Med, New York, NY 10003 USA.4 aut
700a Timinszky, Gyulau Eotvos Lorand Res Network ELKH, Lendulet Lab DNA Damage & Nucl Dynam, Inst Genet, Biol Res Ctr, Szeged, Hungary.4 aut
700a Wang, Zhao-Qiu Leibniz Inst Aging, Fritz Lipmann Inst FLI, Jena, Germany.;Friedrich Schiller Univ Jena, Fac Biol Sci, Jena, Germany.4 aut
700a Yelamos, Joseu Hosp del Mar Med Res Inst IMIM, Canc Res Program, Barcelona, Spain.4 aut
700a Yu, Xiaochunu Westlake Univ, Sch Life Sci, Hangzhou, Peoples R China.4 aut
700a Zaja, Rokou Rhein Westfal TH Aachen, Inst Biochem & Mol Biol, Aachen, Germany.4 aut
700a Ziegler, Mathiasu Univ Bergen, Dept Biomed, Bergen, Norway.4 aut
710a Rhein Westfal TH Aachen, Inst Biochem & Mol Biol, Aachen, Germany.b Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England.4 org
773t The FEBS Journald : John Wiley & Sonsg 289:23, s. 7399-7410q 289:23<7399-7410x 1742-464Xx 1742-4658
856u https://doi.org/10.1111/febs.16142y Fulltext
856u https://uu.diva-portal.org/smash/get/diva2:1740444/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
856u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.16142
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-497477
8564 8u https://doi.org/10.1111/febs.16142

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy